Dr Kyriakopoulos on the Investigation of Masofaniten Plus Enzalutamide in mCRPC
Season 10, Episode 18, Mar 07, 10:45 PM
Dr Kyriakopoulos sheds light on the potential synergy and pharmacokinetic interactions between masofaniten and enzalutamide when used in combination for patients with prostate cancer; contextualizes safety and pharmacokinetic findings from the phase 1 portion of a phase 1/2 study; and outlines key objectives of the agent’s ongoing evaluation in the phase 2 portion of the study.